Inflammatory Biomarkers and Serum Fatty Acids in High-Risk Populations: A Research Protocol
Keywords:
Hypertension, systolic blood pressure, diastolic blood pressure, Biomarkers, serum fatty acidsAbstract
Background: Advances in hypertension management have resulted in a growing number of survivors in the United States. Despite the success of treatments, patients face long-term challenges and changes in health, and with the likelihood of developing more age-related comorbid disorders, related to cardiovascular, renal, pulmonary conditions, and stroke due to uncontrolled blood pressure and a reduction in life expectancy. This study hypothesizes that the increased risk of morbidity and mortality may be due to increased fat intake, resulting in the acceleration of hypertension.
Methods: To address these questions, this study leverages an existing TLIP P-50 project (5P50MD01347-04) at Meharry Medical College in Nashville, TN. Participants will be examined at baseline and prospectively followed at 6, 12, 24, and 36 months to address three specific aims:
Results:1) to examine differences at baseline and in prospective rate of change of metabolic fatty acid assays as a function of blood Pressure progression; 2) to examine differences at baseline and in prospective rate of change of bio- markers assays as a function of Blood Pressure progression; 3) Inflammatory Bio markers and metabolic acid assay in relation to reduction of comorbidities associated with blood pressure.
Conclusions: This study will determine whether monitoring inflammatory biomarkers and serum fatty acid assays over time can detect the progression of hypertension, with independent effects or through the interaction of behavioral factors in high-risk populations, and whether this approach can reduce the risk of age-related morbidities. Such information is necessary to define the risk population and to selectively target inflammatory biomarkers and fatty acid assays with the most effective efficacy and potential to reduce the risk of age-related morbidities.
References
[1]. Oster P, Arab L, Schellenberg B, Hueck CC, Mordasini R, Schlierf G. Blood pressure and adipose tissue linoleic acid. Res Exp Med (Berl). 1979; 175:287-291.
[2]. Miettinen TA, Naukkarinen V, Huttunen JK, Mattila S, Kumlin T. Fatty-acid composition of serum lipids predicts myocardial infarction. Br Med J. 1982; 285:993-996.
[3]. Wood DA, Butler S, Riemersma RA, Thomson M, Oliver MF. Adipose tissue and platelet fatty acids and coronary heart disease in Scottish men. Lancet. 1984; 2:117-121.
[4.]. Berry EM, Hirsch J. Does dietary linolenic acid influence blood pressure? Am J Clin Nutr. 1986; 44:336-340.
[5]. Ciocca S, Arca M, Montali A, Fazio S, Bucci A, Angelico F. Lack of association between arterial blood pressure and erythrocyte fatty acid composition in an Italian population sample. Scand J Clin Lab Invest. 1987; 47:105-110.
[6]. Rubba P, Mancini M, Fidanza F, Gautiero G, Salo M, Nikkari T, Elton R, Oliver MF. Adipose tissue fatty acids and blood pressure in middle-aged men from southern Italy. Int J Epidemiol. 1987; 16:528-531
[7]. Wood DA, Riemersma RA, Butler S, Thomson M, Macintyre C, Elton RA, Oliver MF. Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease. Lancet. 1987; 1:177-182.
[8]. Cambien F, Warnet J-M, Vernier V, Ducimetiere P, Jacqueson A, Flament C, Orssaud G, Richard J-L, Claude J-R. An epidemiologic appraisal of the associations between the fatty acids esterifying serum cholesterol and some cardiovascular risk factors in middle-aged men. Am J Epidemiol. 1988; 127:75-86.
[9]. DeBacker G, DeCraene I, Rosseneu M, Vercaemst R, Kornitzer M. Relationship between serum cholesteryl ester composition, dietary habits and coronary risk factors in middle-aged men. Atherosclerosis. 1989; 78:237-243.
[10]. Leng GC, Smith FB, Fowkes FGR, Horrobin DF, Ells K, Morse-Fisher N, Lowe GDO. Relationship between plasma essential fatty acids and smoking, serum lipids, blood pressure and haemostatic and rheological factors. Prostaglandins Leukot Essent Fatty Acids. 1994; 51:101-108.
[11]. Dietary Guidelines for Americans. The U.S. Department of Health and Human Services and the U.S. Department of Agriculture; 2005
[12]. Wang, L., Manson, J. E., Forman, J. P., Gaziano, J. M., Buring, J. E., & Sesso, H. D. (2010). Dietary fatty acids and the risk of hypertension in middle-aged and older women. Hypertension (Dallas, Texas.:1979), 56(4),598–604. https://doi.org/10.1161/HYPERTENSIONAHA.110.154187
[13]. Tadic M, Sala C, Grassi G, et al. Omega‐3 fatty acids and coronary artery disease: more questions than answers. J Clin Med. 2021;10(11):2495.
[14]. Zhang X, Ritonja JA, Zhou N, Chen BE, Li X. Omega‐3 polyunsaturated fatty acids intake and blood pressure: a dose‐response meta‐analysis of randomized controlled trials. J Am Heart Assoc. 2022;11(11): e025071
[15]. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat. Rev. Nephrology. 2020; 16:223–237. doi: 10.1038/s41581-019-0244-2.
[16]. Heidenreich PA, et al. Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation. 2011; 123:933–944. doi: 10.1161/CIR.0b013e31820a55f5.
[17]. Hall WL. Dietary saturated and unsaturated fats as determinants of blood pressure and vascular function. Nutrition. Res. Rev. 2009; 22:18–38. doi: 10.1017/S095442240925846X.
[18]. Nestel PJ. Dietary fat and blood pressure. Current Hypertension. Rep. 2019; 21:1–6. doi: 10.1007/s11906-019-0918-y.
[19]. Mente A, et al. Association of dietary nutrients with blood lipids and blood pressure in 18 countries: A cross-sectional analysis from the PURE study. Lancet Diabetes Endocrinol. 2017; 5:774–787. doi: 10.1016/S2213-8587(17)30283-8.
[20]. Joosten YA, Israel TL, Williams NA, et. al. Community Engagement Studios: A structured approach to obtaining meaningful input from stakeholders to inform research. Acad Med. 2015;90(12):1646-1650. PMID: 26107879 PMCID: PMC4654264 DOI: 10.1097/ACM.0000000000000794
[21]. Flora Ukoli, Kumar, J., Chike Nzerue, Emmanuel Adediran, Dontal Johnson, Adrian Samuel, & Stephania Miller-Hughes. (2025). Research Design and Methods in Community Team Lifestyle Immersion Program for Chronic Disease Prevention and Control. International Journal of Sciences: Basic and Applied Research (IJSBAR), 77(1), 213-225. https://www.gssrr.org/JournalOfBasicAndApplied/article/view/17539
[22].Hend Alqaderi, Fahad Hegazi, Fahd Al-Mulla, et. al. Salivary Biomarkers as Predictors of Obesity and Intermediate Hyperglycemia in Adolescents. Front Public Health. 2022 Jun 10:10:800373. eCollection 2022. PMID: 35757631 PMCID: PMC9231680 DOI: 10.3389/fpubh.2022.800373
[23]. Anjum Anwar, Gregoire Ruffenach, Aman Mahajan, Mansoureh Eghbali, Soban Umar. Novel biomarkers for pulmonary arterial hypertension. Respir Res. 2016 Jul 20;17(1):88.
PMID: 27439993 PMCID: PMC4955255 DOI: 10.1186/s12931-016-0396-6
[24]. Thomas J Wang, Philimon Gona, Martin G Larson, et. al. Multiple biomarkers and the risk of incident hypertension. Hypertension. 2007 Mar;49(3):432-8. Epub 2007 Jan 22.
PMID: 17242302 DOI: 10.1161/01.HYP.0000256956. 61872.aa
Downloads
Published
Issue
Section
License
Copyright (c) 2026 International Journal of Sciences: Basic and Applied Research (IJSBAR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who submit papers with this journal agree to the following terms.
